Mateo, Jose <br/><br/>
Successful suppression using Rituximab of a factor VIII inhibitor in a boy with severe congenital haemophilia: an example of a significant decrease of treatment costs.  [electronic resource] 

 -  Thrombosis and haemostasis  Feb 2006 
 - 386-7 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0340-6245 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Autoantibodies--blood<br/>B-Lymphocytes--drug effects<br/>Factor VIII--immunology<br/>Health Care Costs<br/>Hemophilia A--drug therapy<br/>Humans<br/>Infant<br/>Male<br/>Rituximab